Rodman David Malcom bought MLYS
April 13, 2026 · Form 4 insider transaction
Rodman David Malcom bought 6,349 shares of Mineralys Therapeutics, Inc. at $1.08 per share, a transaction worth $6.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,349
Price
$1.08
Total value
$6.9K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 13, 2026
Filing dateApril 15, 2026
Shares owned after82,489
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.